| Income Statement |
| Total Revenue | 5.25M |
|
| Revenues (USD) | 5.25M |
| Cost of Revenue | 2.46M |
| Gross Profit | 2.79M |
| Operating Expenses | 6.72M |
| Research and Development Expense | 992.00K |
| Selling, General and Administrative Expense | 5.73M |
| Operating Income | -3.93M |
| Interest Expense | 344.00K |
| Net Income | -6.56M |
| Net Income Common Stock | -6.56M |
| Net Income Common Stock (USD) | -6.56M |
| Consolidated Income | -6.56M |
| Earnings per Basic Share | -4.70 |
| Earnings per Basic Share (USD) | -4.70 |
| Earnings per Diluted Share | -4.70 |
| Earning Before Interest & Taxes (EBIT) | -6.21M |
| Earning Before Interest & Taxes (USD) | -6.21M |
| Weighted Average Shares | 1.39M |
| Weighted Average Shares Diluted | 1.39M |
| Balance Sheet |
| Cash and Equivalents | 2.86M |
| Cash and Equivalents (USD) | 2.86M |
| Trade and Non-Trade Receivables | 2.59M |
| Current Assets | 9.44M |
| Property, Plant & Equipment Net | 36.00K |
| Total Assets | 10.48M |
| Debt Current | 2.98M |
| Total Debt | 20.26M |
| Current Liabilities | 13.10M |
| Debt Non-Current | 17.28M |
| Total Liabilities | 35.85M |
| Accumulated Retained Earnings (Deficit) | -322.35M |
| Accumulated Other Comprehensive Income | 100.00K |
| Shareholders Equity | -25.38M |
| Shareholders Equity (USD) | -25.38M |
| Assets Non-Current | 1.04M |
| Total Debt (USD) | 20.26M |
| Deferred Revenue | 2.64M |
| Goodwill and Intangible Assets | 923.00K |
| Inventory | 2.03M |
| Liabilities Non-Current | 22.75M |
| Trade and Non-Trade Payables | 3.85M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 3.00K |
| Net Cash Flow from Financing | 4.89M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.84M |
| Capital Expenditure | -2.00K |
| Issuance (Purchase) of Equity Shares | 147.00K |
| Issuance (Repayment) of Debt Securities | 1.75M |
| Net Cash Flow from Investing | -2.00K |
| Net Cash Flow from Operations | -3.02M |
| Effect of Exchange Rate Changes on Cash | -25.00K |
| Share Based Compensation | 1.55M |